Aquestive Therapeutics, Inc. (NASDAQ:AQST) Given Consensus Recommendation of “Buy” by Brokerages
Aquestive Therapeutics, Inc. (NASDAQ:AQST – Get Free Report) has been given a consensus rating of “Buy” by the seven brokerages that are currently covering the stock, MarketBeat reports. Seven analysts have rated the stock with a buy recommendation. The average 1 year price objective among brokers that have updated their coverage on the stock in […]
Aquestive Therapeutics, Inc. (NASDAQ:AQST – Get Free Report) has been given a consensus rating of “Buy” by the seven brokerages that are currently covering the stock, MarketBeat reports. Seven analysts have rated the stock with a buy recommendation. The average 1 year price objective among brokers that have updated their coverage on the stock in […]
